醫藥品原料藥 (API)的印度市場:預測與分析 (2018年)
Market for Active Pharmaceutical Ingredients in India - Forecast and Analysis 2018
|出版日期||內容資訊||英文 165 Pages
|醫藥品原料藥 (API)的印度市場:預測與分析 (2018年) Market for Active Pharmaceutical Ingredients in India - Forecast and Analysis 2018|
|出版日期: 2019年09月01日||內容資訊: 英文 165 Pages||
印度醫藥品產業的成長是最快的市場之一，以數量為準成為在世界中第3名。印度的醫藥品原料藥 (API) 市場收益，預計2020年末為超過止為55億美元。
本報告提供印度的醫藥品原料藥 (API) 市場相關調查，API市場簡介，全球市場，亞太地區市場，及印度市場上分析與預測，及主要企業簡介等資訊。
India has one of the fastest growing pharmaceutical industries in the world, ranking third in terms of volume. The cities of Bangalore, Hyderabad, Mumbai, Ahmedabad, and others have become lucrative pharmaceutical hubs in India. The Indian government has also been dedicatedly encouraging the growth of drug manufacturing in India. However, the lack of patent protection is a huge issue facing the Indian drugs market at present. Lack of intellectual property rights has made the industry undesirable to many foreign companies looking to invest in the country.
The Indian market for active pharmaceutical ingredients (APIs) has been growing strongly in recent years, led by the generic and biosimilar markets. The patent expiries of several blockbuster drugs that has been ongoing is believed to further contribute to the growth of the active pharmaceutical ingredient market in India. The market for APIs in India is expected to cross revenues of USD 5.5 billion by the end of 2020, with high growth expected post 2020 as well.
The market for APIs in India remains dominated by the synthetic API market since the last decade. The rise of the biotechnology sector in India has caused an increase in biotech API market revenues as well, though the segment continues to lag behind the synthetic API market. It is expected that the synthetic API market will continue to lead the industry in the years to come.
Aruvian Research analyzes the market for APIs in India in its research report Market for Active Pharmaceutical Ingredients in India - Forecast and Analysis 2018. The data covered in this report ranges from 2008 till 2020. Let us take a look at what the report focusses on.
The report begins with an introduction to Active Pharmaceutical Ingredients and then moves on to briefly analyze the global market for active pharmaceutical ingredients. We include an overview of the global market for APIs and a look at the global market's revenues.
Section D of the report analyzes the market for active pharmaceutical ingredients in Asia Pacific through an industry overview, industry revenues, and a look at the various therapeutic applications of APIs in the Asia Pacific region. Impacts on the Asia Pacific active pharmaceutical ingredients market are also analyzed.
With section E, we begin our analysis of the market for active pharmaceutical ingredients in India. This section analyzes the industry through basic statistics and industry revenues. Industry segmentation through the biotech segment and the synthetic API market in India is included in the report, along with a forecast of the industry till 2020.
An analysis of the major industry players, both global and domestic, are included in the report. The major players are analyzed through a business segment profile, a look at their major products and services, and a SWOT analysis. The analysis looks at the 20 top companies operating in the Indian API market.
Research methodology for the report concludes this comprehensive report on the market for active pharmaceutical ingredients in India till 2020.